Medullary thyroid carcinoma: A 20-year experience from a centre in South India

ANZ Journal of Surgery

Volumn 77, Issue 3, 2007, Pages 130-134

  Finny, Philip ^a   Jacob, Jubbin J ^a   Thomas, Nihal ^a   Philip, Jim ^a   Rajarathnam, Simon ^a   Oommen, Regi ^a   Aravindan, Nair ^a   Seshadri, Mandalam S ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

131I metaiodobenzylguanidine scanning; Calcitonin; Medullary thyroid carcinoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; IODINE 131;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CHILD; CLINICAL ARTICLE; ENDOCRINE DISEASE; EXPERIENCE; FEMALE; HEALTH CENTER; HUMAN; HUMAN TISSUE; HYPERCALCITONINEMIA; INDIA; INSTITUTIONAL CARE; LYMPHADENOPATHY; MALE; MEDICAL RECORD REVIEW; MINIMAL RESIDUAL DISEASE; NECK DISSECTION; PROGNOSIS; SWELLING; THYROID CARCINOMA; THYROID GLAND; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33846892732     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2006.03992.x     Document Type: Article

References (18)

1. Bergholm U, Adami HO, Bergstrom R et al. Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 24 patients in Sweden from 1959 through 1981. Cancer 1989; 63: 1196-204.
2. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997; 79: 564-73.
3. Hundahl SA, Fleming ID, Fremgen AM, Mehek HR. A National Cancer Data Base report on 53,856 cases of thyroid cancinoma treated in the U.S., 1985-1995. Cancer 1998; 83: 2638-48.
4. Sudeep K, Naik DB, Anjali, RS et al. Differentiated thyroid carcinomas - experiences from an institution in South India. Presented at The 35th Annual Conference of Endocrine Society of India, New Delhi, India; 11-13 November 2005.
5. Schroder S, Holl K, Padberg BC. Pathology of sporadic and hereditary medullary thyroid carcinoma. Recent Results Cancer Res. 1992; 125: 19-45.
6. Donis-Keller H, Dou S, Chi D et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet. 1993; 2: 851-6.
7. Desai S S.,Sarkar S, Borges AM. A study of histopathological features of medullary carcinoma of the thyroid: cases from a single institute in India. Indian J. Cancer 2005; 42: 25-9.
8. Ball, D.W., Baylin, S.B de Bustros A.C. Medullary thyroid carcinoma. In: Braverman LE and Utiger RE (eds) Werner and Ingbar's the Thyroid, 7th edn. Philadelphia: Lippincott Williams & Wilkins, 1996; 946-60.
9. Modigliani E, Cohen R, Campos JM et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin. Endocrinol. (Oxf.) 1998; 48: 265-73.
10. Raue F. German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary thyroid carcinoma/multiple endocrine neoplasia type 2. Arch. Surg. 1998; 383: 334-6.
11. Leboulleux S, Baudin E, Travagli J-P, Schlumberger M. Medullary thyroid carcinoma. Clin. Endocrinol. (Oxf.) 2004; 61: 299-310.
12. Clayman GL, El-Baradie TS. Medullary thyroid cancer. Otolaryngol. Clin. North Am. 2003; 128: 93-8.
13. Saad, MF, Ordonez NG, Rashid RK et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 1984; 63: 319-42.
14. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000; 88: 1139-48.
15. Brierley J, Tsang R, Simpson WJ, Gospodarowicz M, Sutcliffe S, Panzarella T. Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996; 6: 305-10.
16. Schlumberger M, Gardet P, de Vathaire F, Sarrazin D et al. External radiotherapy and chemotherapy in MTC patients. In: Calmettes C, Guliana JM. (eds). Medullary thyroid carcinoma. Paris: John Libbery Eurotext Ltd, 1991; 213-20.
17. 99m Tc) MDP. An evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J. Nucl. Med. 1988; 29: 33-8.
18. Hellman DE, Kartchner M, Van Antwerp JD et al. Radioiodine in the treatment of medullary carcinoma of the thyroid. J. Clin. Endocrinol. Metab. 1979; 48: 451-5.